PDCD1 and bladder transitional cell carcinoma: There was no statistically significant in the expression of PD-1 between tumor samples and normal samples in bladder urothelial carcinoma (BLCA), esophageal carcinoma (ESCA), colon adenocarcinoma (COAD), rectum adenocarcinoma (READ), and stomach adenocarcinoma (STAD).